NUCRYST Pharmaceuticals announces year-e...(140 135 Capital assets - net...),Health

Capital assets - net 12,734 11,350

Intangible assets - net 807 816

-------------------------------------------------------------------------

$ 51,299 $ 45,892

-------------------------------------------------------------------------

-------------------------------------------------------------------------

LIABILITIES AND SHAREHOLDERS' EQUITY

Current

Accounts payable and accrued liabilities $ 3,650 $ 2,261

Accounts payable and accrued liabilities to

related party 67 45

Deferred lease inducement 111 -

-------------------------------------------------------------------------

3,828 2,306

Long term deferred lease inducement 726 -

-------------------------------------------------------------------------

4,554 2,306

-------------------------------------------------------------------------

Guarantees

Commitments

Shareholders' equity

Common shares no par value, unlimited shares

authorized: issued and outstanding -

18,367,563 and 18,309,613 shares at

December 31, 2007 and 2006, respectively 82,776 82,672

Additional paid-in capital 1,511 482

Accumulated other comprehensive income (loss) 557 (5,490)

Accumulated deficit (38,099) (34,078)

-------------------------------------------------------------------------

Total shareholders' equity
'/>"/>